Your browser doesn't support javascript.
loading
Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.
Joseph, Richard W; Kapur, Payal; Serie, Daniel J; Parasramka, Mansi; Ho, Thai H; Cheville, John C; Frenkel, Eugene; Parker, Alexander S; Brugarolas, James.
Afiliação
  • Joseph RW; Division of Medical Oncology, Departments of Health Sciences Research and Medicine and Division of Cancer Biology, Mayo Clinic Florida, Jacksonville, Florida; Department of Pathology, Kidney Cancer Program, Simmons Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Internal
  • Kapur P; Division of Medical Oncology, Departments of Health Sciences Research and Medicine and Division of Cancer Biology, Mayo Clinic Florida, Jacksonville, Florida; Department of Pathology, Kidney Cancer Program, Simmons Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Internal
  • Serie DJ; Division of Medical Oncology, Departments of Health Sciences Research and Medicine and Division of Cancer Biology, Mayo Clinic Florida, Jacksonville, Florida; Department of Pathology, Kidney Cancer Program, Simmons Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Internal
  • Parasramka M; Division of Medical Oncology, Departments of Health Sciences Research and Medicine and Division of Cancer Biology, Mayo Clinic Florida, Jacksonville, Florida; Department of Pathology, Kidney Cancer Program, Simmons Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Internal
  • Ho TH; Division of Medical Oncology, Departments of Health Sciences Research and Medicine and Division of Cancer Biology, Mayo Clinic Florida, Jacksonville, Florida; Department of Pathology, Kidney Cancer Program, Simmons Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Internal
  • Cheville JC; Division of Medical Oncology, Departments of Health Sciences Research and Medicine and Division of Cancer Biology, Mayo Clinic Florida, Jacksonville, Florida; Department of Pathology, Kidney Cancer Program, Simmons Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Internal
  • Frenkel E; Division of Medical Oncology, Departments of Health Sciences Research and Medicine and Division of Cancer Biology, Mayo Clinic Florida, Jacksonville, Florida; Department of Pathology, Kidney Cancer Program, Simmons Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Internal
  • Parker AS; Division of Medical Oncology, Departments of Health Sciences Research and Medicine and Division of Cancer Biology, Mayo Clinic Florida, Jacksonville, Florida; Department of Pathology, Kidney Cancer Program, Simmons Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Internal
  • Brugarolas J; Division of Medical Oncology, Departments of Health Sciences Research and Medicine and Division of Cancer Biology, Mayo Clinic Florida, Jacksonville, Florida; Department of Pathology, Kidney Cancer Program, Simmons Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Internal
J Urol ; 195(1): 180-7, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26300218
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article